Bert Fish has returned to public control, under the Southeast Volusia Hospital District.
In February, a judge overturned the $80 million merger, ruling the 21 closed-door meetings surrounding the merger were in violation of the state’s Sunshine Law and that the two groups’ attempts to “cure” the violations by reholding the meetings were not an appropriate remedy.
The future of the New Smyrna hospital remains uncertain, but many experts believe it will need to merge or sell to another system to remain viable, according to the report.
As part of the separation agreement, Adventist will pay Bert Fish Medical Center $1.35 million within the next 30 days and will pay the Volusia hospital taxing district $1.5 million, according to the report.
Read the Orlando Sentinel report on Bert Fish Medical Center.
Related Articles on Bert Fish Medical Center:
Judge Approves Plan to Unravel Adventist, Bert Fish Merger
Florida’s Bert Fish Expected to Preserve Finances in Shift Back to Public Ownership
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
